Find out all about your favorite commercial!

Advertisers

Advertisers of the Keytruda TV Spot, 'Roger: A Good Father'

Keytruda TV commercial - Roger: A Good Father
Keytruda

Keytruda is a brand name for pembrolizumab, an immunotherapy drug developed and marketed by Merck & Co. It was approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of adva...

What the Keytruda TV commercial - Roger: A Good Father is about.

Keytruda TV commercial - Roger: A Good Father

Title: Keytruda TV Spot, 'Roger: A Good Father'

Introduction:In the heartwarming Keytruda TV Spot, 'Roger: A Good Father,' we witness the story of a resilient father named Roger and his unwavering dedication to his family. This emotional commercial captures the essence of family bonds, highlighting the strength and love that can overcome even the toughest challenges.

Synopsis:The advertisement opens with a montage of everyday moments in Roger's life. He is seen coaching his daughter's soccer team, playing catch with his son in the backyard, and supporting his spouse during a family gathering. These snippets depict Roger as a loving and engaged father, always there for his family.

However, the mood shifts as the commercial hints at a darker reality. The screen fades to black, and we hear Roger's voice sharing the devastating news of his cancer diagnosis. The somber tone and emotional intensity of his words evoke a powerful response from viewers, capturing their attention.

As Roger faces the uncertainty of his diagnosis, we see him engaging in medical appointments and undergoing treatments. These scenes showcase the resilience and determination of both Roger and his family. They stand as pillars of support beside him, providing strength and encouragement throughout his journey.

The turning point of the ad arrives when Roger's oncologist mentions Keytruda as a potential treatment option. Keytruda, a groundbreaking immunotherapy drug, emerges as a beacon of hope in Roger's battle against cancer. The commercial highlights the drug's effectiveness and its ability to unleash the power of the immune system to fight cancer cells.

Roger's story takes an uplifting turn as the commercial moves forward. Through a series of shots, we witness the gradual improvement in his health while he continues to spend quality time with his family. The moments of joy and connection he shares with his loved ones demonstrate the impact that Keytruda has on his life. Roger's transformation serves as an inspiration and a testament to the drug's potential.

The commercial concludes with a powerful image of Roger, now in remission, surrounded by his family, radiating confidence and gratitude. A voiceover narrates an uplifting message, highlighting Keytruda's role in Roger's journey and its continued commitment to fighting against cancer.

Impact:The Keytruda TV Spot, 'Roger: A Good Father,' transcends the typical drug commercial narrative by focusing on the emotional and personal aspect of a cancer journey. It celebrates the strength of family bonds, instilling hope and determination in viewers who may be facing similar challenges.

By showcasing the effectiveness of Keytruda

Keytruda TV commercial - Roger: A Good Father produced for Keytruda was first shown on television on October 25, 2020.

Frequently Asked Questions about keytruda tv spot, 'roger: a good father'

Since then, Theresa has been undetectable for over a year, and she continues treatment with Keytruda, with little to no side effects. Her family remains hopeful and grateful that everything is going well for Theresa and they pray for her continued strength.

Keytruda works by binding to PD-1 and therefore blocking the cancer cells from using their own protein to slot into the same spot and switch off the immune cells. So with Keytruda, the T-cells do their job and effectively attack the cancer. Keytruda is also known as an anti PD-1 immunotherapy.

Keytruda given every 3 weeks reduced the risk of cancer spreading, growing, or getting worse by 42% compared to Yervoy. Half (50%) of the patients who received Keytruda every 3 weeks were alive at 4.1 months, compared to 2.8 months for patients receiving Yervoy.

KEYTRUDA is a prescription medicine used to treat a kind of cancer called triple-negative breast cancer (TNBC). KEYTRUDA may be used with chemotherapy medicines when your breast cancer has returned and cannot be removed by surgery or has spread, and tests positive for “PD-L1.” PD-L1 = programmed death ligand 1.

In one clinical study of people with urothelial cancer that couldn't be treated by certain chemotherapy drugs: 20% of people who took Keytruda had their cancer partially go away. 10% of people who took Keytruda had their cancer completely go away.

KEYTRUDA blocks the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA is a type of immunotherapy that works by blocking the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA helps the immune system do what it was meant to do: detect and fight cancer cells.

Some patients can stay on KEYTRUDA for up to a year or two. Your doctor will decide how long you will be on treatment. Always talk to your doctor about what to expect while taking KEYTRUDA.

KEYTRUDA blocks the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA is a type of immunotherapy that works by blocking the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA helps the immune system do what it was meant to do: detect and fight cancer cells.

Some patients can stay on KEYTRUDA for up to a year or two. Your doctor will decide how long you will be on treatment. Always talk to your doctor about what to expect while taking KEYTRUDA.

KEYTRUDA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time.

Keytruda given every 3 weeks reduced the risk of cancer spreading, growing, or getting worse by 42% compared to Yervoy. Half (50%) of the patients who received Keytruda every 3 weeks were alive at 4.1 months, compared to 2.8 months for patients receiving Yervoy.

Pembrolizumab (brand name: Keytruda) from Merck was first approved in September 2014 and since that time over 19 cancer uses have been approved by the FDA. It treats cancers ranging from advanced skin cancer, to bladder cancer to lung cancer.

Videos

Watch Keytruda TV Commercial, 'Roger: A Good Father'

We analyzed TV commercials placed on popular platforms and found the most relevant videos for you:

Agenices

Agenices of the Keytruda TV Spot, 'Roger: A Good Father'

Keytruda TV commercial - Roger: A Good Father
Initiative

A company initiative is a pro-active effort undertaken by a business to achieve a specific objective or goal. These initiatives can vary widely in scope and focus, including everything from internal p...

Products

Products Advertised

Keytruda
TV commercials

Similar commercials

Keytruda TV Spot, 'Known For: Loving Parent, Lessons That Matter, Free Spirit'
Duluth Trading Company TV Spot, 'All the Merry You Can Carry'
Ninja Foodi Grill TV Spot, 'Grill and Fry'
Duluth Trading Company TV Spot, 'Generations'
Duluth Trading Company TV Spot, 'Hallmark Channel: Countdown to Christmas' Song by Will Schaefer
Duluth Trading Company Alaskan Hardgear TV Spot, 'Live Life' Song by Jules Gaia
2018 Volkswagen Atlas TV Spot, 'America' Song by Simon & Garfunkel [T1]
Ball Aluminum Cup TV Spot, 'Recycling Has Never Been So Refreshing: Disposables Section'
Smile Direct Club Nighttime Aligners TV Spot, 'Straighten Your Teeth While You Sleep'
Duluth Trading Company Buck Naked Underwear TV Spot, 'Mousetrap'
Keytruda TV Spot, 'Bed and Breakfast'
Keytruda TV Spot, 'The Moment: Begins'